Page last updated: 2024-08-24

u 37883a and cromakalim

u 37883a has been researched along with cromakalim in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (41.67)18.2507
2000's7 (58.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carroll, WA; Coghlan, MJ; Gopalakrishnan, M1
Choe, E; Ferrara, J; Flint, L; Franklin, E; Grivas, T; Hyman, A; Lippton, H1
Khan, SA; Meisheri, KD; Ohrnberger, CE1
Cipkus-Dubray, LA; Humphrey, SJ; Jones, AW; Khan, SA; Meisheri, KD; Smith, MP1
Anwar, M; Banister, RE; Feng, CJ; Kadowitz, PJ; Kaye, AD; Nossaman, BD1
Barrett-Jolley, R; Everitt, D; Köppel, H; Quayle, JM; Wellman, GC1
Anwar, M; De Witt, BJ; Feng, CJ; Kadowitz, PJ; Kaye, AD; Nossaman, BD; Smith, DE1
Ikeda, S; Kyotani, S; Min, KY; Mori, H; Nagaya, N; Nakanishi, N; Ninomiya, I; Oya, H; Shimouchi, A; Shirai, M1
Bivalacqua, TJ; Champion, HC; Coy, DH; Kadowitz, PJ; Murphy, WA; Pierce, RL1
Ito, Y; Naito, S; Teramoto, N; Tomoda, T; Yunoki, T1
Al Abed, A; Brock, JA; Tan, JH1
Baun, M; Boni, LJ; Hay-Schmidt, A; Jansen-Olesen, I; Olesen, J; Ploug, KB1

Reviews

1 review(s) available for u 37883a and cromakalim

ArticleYear
Recent developments in the biology and medicinal chemistry of potassium channel modulators: update from a decade of progress.
    Journal of medicinal chemistry, 2001, May-24, Volume: 44, Issue:11

    Topics: Adenosine Triphosphate; Angina Pectoris; Arrhythmias, Cardiac; Asthma; Calcium; Ion Channel Gating; Myocardial Ischemia; Potassium Channel Blockers; Potassium Channels; Urinary Incontinence

2001

Other Studies

11 other study(ies) available for u 37883a and cromakalim

ArticleYear
Femoral vasodilation to cromakalim is blocked by U37883A, a non-sulphonylurea that selectively inhibits KATP channels.
    The Journal of pharmacy and pharmacology, 1995, Volume: 47, Issue:3

    Topics: Adamantane; Analysis of Variance; Animals; Benzopyrans; Cromakalim; Dogs; Drug Interactions; Femur; Injections, Intravenous; Isoproterenol; Morpholines; Nitroglycerin; Potassium Channels; Pyrroles; Regional Blood Flow; Serotonin; Serotonin Receptor Agonists; Vasodilation; Vasodilator Agents

1995
Synergistic effects of glyburide and U-37883A, two structurally different vascular ATP-sensitive potassium channel antagonists.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 267, Issue:1

    Topics: Adamantane; Adenosine Triphosphate; Animals; Benzopyrans; Cromakalim; Drug Synergism; Gallopamil; Glyburide; In Vitro Techniques; Ion Channel Gating; Male; Mesenteric Arteries; Minoxidil; Morpholines; Potassium Channels; Pyrroles; Rabbits; Vasodilation

1993
4-morpholinecarboximidine-N-1-adamantyl-N'-cyclohexylhydrochloride (U-37883A): pharmacological characterization of a novel antagonist of vascular ATP-sensitive K+ channel openers.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 266, Issue:2

    Topics: Adamantane; Adenosine Triphosphate; Animals; Benzopyrans; Blood Pressure; Cats; Cromakalim; Dogs; Female; In Vitro Techniques; Male; Mesenteric Arteries; Minoxidil; Morpholines; Potassium; Potassium Channels; Pyrroles; Rabbits; Rats; Rats, Sprague-Dawley; Vasodilation

1993
Pulmonary vasodilation by ketamine is mediated in part by L-type calcium channels.
    Anesthesia and analgesia, 1998, Volume: 87, Issue:4

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adamantane; Anesthetics, Dissociative; Animals; Arachidonic Acid; Arginine; Blood Pressure; Calcium Channel Blockers; Calcium Channels; Cromakalim; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Ketamine; Lung; Male; Meclofenamic Acid; Morpholines; Potassium Channels; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Vasodilation; Verapamil

1998
Inhibition of vascular K(ATP) channels by U-37883A: a comparison with cardiac and skeletal muscle.
    British journal of pharmacology, 1999, Volume: 128, Issue:4

    Topics: Adamantane; Adenosine Triphosphate; Animals; Cromakalim; In Vitro Techniques; Male; Mesenteric Arteries; Morpholines; Muscle Relaxation; Muscle, Skeletal; Myocardium; Potassium Channel Blockers; Potassium Channels, Inwardly Rectifying; Rats; Rats, Wistar

1999
Analysis of responses of garlic derivatives in the pulmonary vascular bed of the rat.
    Journal of applied physiology (Bethesda, Md. : 1985), 2000, Volume: 89, Issue:1

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adamantane; Allyl Compounds; Animals; Antihypertensive Agents; Antioxidants; Bronchodilator Agents; Cromakalim; Cyclooxygenase Inhibitors; Disulfides; Diuretics; Enzyme Inhibitors; Garlic; Hypertension, Pulmonary; Lung Diseases, Obstructive; Male; Meclofenamic Acid; Morpholines; NG-Nitroarginine Methyl Ester; Plants, Medicinal; Pulmonary Circulation; Rats; Rats, Sprague-Dawley; Respiration; Sulfhydryl Compounds; Sulfinic Acids; Vasoconstrictor Agents

2000
K(ATP) channels predominantly regulate conduit vessel tone in normoxic cat pulmonary arteries in vivo.
    European journal of pharmacology, 2001, Jun-22, Volume: 422, Issue:1-3

    Topics: Adamantane; Adenosine Triphosphate; Animals; Blood Pressure; Cats; Cromakalim; Dose-Response Relationship, Drug; Glyburide; Morpholines; Potassium Channels; Pulmonary Artery; Vasoconstriction; Vasodilator Agents

2001
Analysis of responses to hAmylin, hCGRP, and hADM in isolated resistance arteries from the mesenteric vascular bed of the rat.
    Peptides, 2001, Volume: 22, Issue:9

    Topics: Acetylcholine; Adamantane; Adrenomedullin; Amyloid; Animals; Arginine; Calcitonin Gene-Related Peptide; Cromakalim; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Humans; In Vitro Techniques; Islet Amyloid Polypeptide; Mesenteric Arteries; Morpholines; Nitric Oxide Synthase; Oxadiazoles; Peptide Fragments; Peptides; Perfusion; Potassium Channel Blockers; Quinoxalines; Rats; Receptors, Calcitonin Gene-Related Peptide; Receptors, Islet Amyloid Polypeptide; Receptors, Peptide; Vascular Resistance; Vasodilator Agents

2001
Multiple actions of U-37883A, an ATP-sensitive K+ channel blocker, on membrane currents in pig urethra.
    European journal of pharmacology, 2005, Nov-07, Volume: 524, Issue:1-3

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adamantane; Adenosine Triphosphate; Analysis of Variance; Animals; Barium; Calcium Channel Agonists; Cromakalim; Dose-Response Relationship, Drug; Female; Glyburide; In Vitro Techniques; Membrane Potentials; Morpholines; Muscle Cells; Nitroprusside; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Inwardly Rectifying; Swine; Time Factors; Urethra; Vasodilator Agents

2005
Inhibition of KATP channels in the rat tail artery by neurally released noradrenaline acting on postjunctional alpha2-adrenoceptors.
    The Journal of physiology, 2007, Jun-01, Volume: 581, Issue:Pt 2

    Topics: Adamantane; Adenosine Triphosphate; Animals; Arteries; Calcitonin Gene-Related Peptide; Cromakalim; Dose-Response Relationship, Drug; Electric Impedance; Excitatory Postsynaptic Potentials; Female; Glyburide; In Vitro Techniques; Ion Channel Gating; Morpholines; Muscle, Smooth, Vascular; Norepinephrine; Pinacidil; Potassium Channel Blockers; Potassium Channels; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Sympathetic Nervous System; Tail; Time Factors

2007
K(ATP) channel expression and pharmacological in vivo and in vitro studies of the K(ATP) channel blocker PNU-37883A in rat middle meningeal arteries.
    British journal of pharmacology, 2008, Volume: 154, Issue:1

    Topics: Adamantane; Animals; ATP-Binding Cassette Transporters; Blotting, Western; Cromakalim; Data Interpretation, Statistical; Diuretics; Guanidines; In Vitro Techniques; KATP Channels; Male; Meningeal Arteries; Microscopy, Video; Morpholines; Multidrug Resistance-Associated Proteins; Pinacidil; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Inwardly Rectifying; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Drug; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonylurea Receptors; Vasodilator Agents

2008